22.08.2023

ARTIFICIALIRIS SELECT – HumanOptics launches new color category of premium iris implant

As a leading provider of premium implants for ophthalmic surgery, HumanOptics has been successfully distributing the globally unique and FDA-approved CUSTOMFLEX® ARTIFICIALIRIS for more than 20 years for patients suffering from aniridia. The company now announces the launch of a new color category of the product at ESCRS 2023 in Vienna. The premium implant ARTIFICIALIRIS SELECT […]

    *Mandatory field

    HumanOptics represented at the 43rd ESCRS Congress in Copenhagen

    News
    ESCRS 2025 News

    We are pleased to announce that HumanOptics will be participating in the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen, Denmark, from 12 to 16 September 2025. The ESCRS Congress is one of the most important international platforms for ophthalmologists, researchers and companies in the field of cataract and […]